Media Articles Related to Ortho (Ethinyl Estradiol)
Source: MedicineNet Addison Disease Specialty [2016.08.17]
Title: Orthostatic Hypotension
Category: Diseases and Conditions
Created: 6/11/2009 12:00:00 AM
Last Editorial Review: 8/17/2016 12:00:00 AM
Help Your Patients Ski Safely This Winter
Source: Medscape Family Medicine Headlines [2016.11.30]
Trying to squeeze all their money's worth out of an expensive lift ticket and a long trip to the mountains can set patients up for an injury that will cut ski season short. Here's what to do instead.
Source: Medscape Critical Care Headlines [2016.11.29]
How can clinicians cope with the feelings of guilt when treatment-related complications and errors occur? This editorial explores the matter.
Current Orthopaedic Practice
10 Questions: Rep. Tom Price, MD (R-Ga.)
Source: MedPage Today Surgery [2016.11.29]
(MedPage Today) -- What's the biggest barrier to practicing medicine today? Medical decisions being made by nonmedical people, says Rep. Tom Price, MD (R-Ga.), an orthopedic surgeon who has served in Congress since 2005.
Trump Picks Rep. Tom Price, MD, to Lead HHS
Source: Medscape Family Medicine Headlines [2016.11.28]
The Georgia orthopaedic surgeon would bring a small-government outlook and a strong resume to the nation's top healthcare job.
Medscape Medical News
Published Studies Related to Ortho (Ethinyl Estradiol)
[Efficacy and safety of a combined oral contraceptive containing drospirenone 3
mg and ethinylestradiol 20 µg in the treatment of premenstrual dysphoric
disorder: a randomized, double blind placebo-controlled study]. [Article in Chinese] 
with placebo in reducing symptoms of premenstrual dysphoric disorder (PMDD)... CONCLUSIONS: YAZ could improve symptoms of PMDD better than placebo, while
An overview of four studies of a continuous oral contraceptive (levonorgestrel 90
mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual
and premenstrual syndrome (PMS)... CONCLUSIONS: These data, although not consistent, indicate that continuous LNG/EE
Bond strength of orthodontic light-cured resin-modified glass ionomer cement. [2011.04]
The purpose of this study was to compare the bond strengths and debonded interfaces achieved with light-cured resin-modified glass ionomer cement (RMGIC) and conventional light-cured composite resin. In addition, the effects of acid etching and water contamination were examined... Enamel surfaces, with or without water contamination and with or without acid etching, had the same or a greater bond strength than Transbond.
In-vitro evaluation of various treatments to prevent demineralization next to orthodontic brackets. [2010.12]
INTRODUCTION: One common negative side effect of orthodontic treatment with fixed appliances is the development of incipient caries lesions around brackets, particularly in patients with poor oral hygiene. Bio-available minerals from cement containing amorphous calcium phosphate (ACP) might facilitate remineralization and inhibit lesion development. Our objective was to compare the potential of ACP-containing resin cement, fluoride varnish, resin sealer, and MI Paste (GC America, Alsip, Ill) under similar in-vitro conditions to prevent incipient caries lesions next to brackets on teeth... CONCLUSIONS: Both light-cured filled resin (Pro-seal) and fluoride varnish (Vanish) might prevent enamel demineralization next to orthodontic brackets exposed to cariogenic conditions, but the observed positive effects of Aegis-Ortho and MI Paste were not significant. Copyright (c) 2010 American Association of Orthodontists. Published by Mosby, Inc. All rights reserved.
Periodontal regeneration with or without limited orthodontics for the treatment of 2- or 3-wall infrabony defects. [2010.12]
BACKGROUND: Limited orthodontics are shown to be effective in the correction of infrabony defects. Studies have also demonstrated the efficacy of using enamel matrix derivative (EMD) with demineralized freeze-dried bone allograft (DFDBA) to treat infrabony defects. This study aims to compare the clinical efficacy of limited orthodontics combined with EMD/DFDBA in the treatment of 2- or 3-wall infrabony defects... CONCLUSION: Although both treatment modalities were effective in managing 2- or 3-wall infrabony defects, limited orthodontics provided an additional benefit to EMD/DFDBA in 2-wall defects.
Clinical Trials Related to Ortho (Ethinyl Estradiol)
The Effect of an Adhesive Overlay on the Delivery of Contraceptive Hormones From ORTHO EVRA� in Healthy Women [Completed]
The purpose of this study is to assess the bioequivalence of the contraceptive hormones of
ORTHO EVRA when the patch is applied with and without an adhesive overlay.
Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks [Active, not recruiting]
The purpose of the study is to assess the occurrence of venous thromboembolism (blood
clots), stroke, and heart attack in current users of ORTHO EVRA compared to current users of
norgestimate-containing oral contraceptives with 35 mcg ethinyl estradiol with special
attention to duration of use. The study uses data from the PharMetrics Patient-Centric
Database, which is a medical claims database.
Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen� in Healthy Female Subjects [Completed]
Discontinuation of Lens Wear in New Ortho-k Children (DOEE2) [Active, not recruiting]
Continuous Use of the Contraceptive Patch and the Personal Economic Impact. [Withdrawn]
Dr. Eleanor Drey in the Department of Obstetrics, Gynecology and Reproductive Sciences UCSF
is conducting a study to examine the personal and economic impact of continuous use of ORTHO
EVRA, the contraceptive patch, on menstrual related symptoms for women who report having
severe menstrual related symptoms.